Fil Ltd Upped Its Position in Mylan N V (NASDAQ:MYL) as Price Declined

May 16, 2018 - By Pearl Odom

Mylan N.V. (NASDAQ:MYL) Corporate LogoDuring Q4 2017 the big money sentiment increased to 3. That’s change of 2.67, from 2017Q3’s 0.33. 0 investors sold all, 1 reduced holdings as MYL ratio is positive. 0 grew positions while 3 funds took positions. Funds hold 292,846 shares thus 88.91% more from 2017Q3’s 155,019 shares. Mirae Asset Glob Invests Ltd owns 0.01% invested in Mylan N.V. (NASDAQ:MYL) for 17,231 shs. Van Hulzen Asset Mgmt Lc has invested 1.55% in Mylan N.V. (NASDAQ:MYL). Gulf Intll Bancshares (Uk) Limited has 139,930 shs. Vantage Investment Advsr Lc owns 337 shs or 0% of their US capital.

In 2018Q1 SEC regulatory report was reported Fil Ltd’s holdings in Mylan N V (NASDAQ:MYL) which was upped by 6.62%. Mylan N V (NASDAQ:MYL) stock Sank 5.99% while Fil Ltd bought 343,102 shares. Fil Ltd reported $227.35 million position in Fil Ltd for 2018Q1. Now it holds 5.52 million shares, compared to 5.18 million last quarter. $20.17 billion is the MC of Mylan N V. MYL is touching $39.18 during the last trading session, after increased 1.77%.Currently Mylan N.V. is downtrending after 5.23% change in last May 16, 2017. MYL has 3.20 million shares volume. MYL underperformed by 16.78% the S&P 500.

According to the regulatory report Fil Ltd’s stake in Molson Coors Brewing Co (NYSE:TAP) was reduced by 163,023 shares to 5.19 million shares valued at $391.15M in 2018Q1. It operates about $36.38B US longs. Fil Ltd cut its stake in Sina Corp (NASDAQ:SINA) and reduced Twenty First Centy Fox Inc (NASDAQ:FOXA) position by 287,674 shares for a total of 1.97M shares.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

A total of 14 analysts rate Mylan Inc (NASDAQ:MYL) as follows: 11 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 79% are bullish. (NASDAQ:MYL) has 20 ratings reports on 16 May 2018 according to StockzIntelligence. On Thursday, January 11 the stock has “Buy” rating by Goldman Sachs. On Monday, December 4 the rating was maintained by UBS with “Buy”. On Thursday, March 1 the stock of Mylan N.V. (NASDAQ:MYL) has “Hold” rating given by Cantor Fitzgerald. On Thursday, March 1 the company was maintained by UBS. On Thursday, March 15 the stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Mizuho. In Thursday, April 12 report Mizuho maintained the stock with “Buy” rating. The stock rating was upgraded by Morgan Stanley to “Overweight” on Tuesday, March 6. On Tuesday, February 6 BMO Capital Markets maintained the shares of MYL in report with “Buy” rating. On Thursday, December 21 Cantor Fitzgerald maintained Mylan N.V. (NASDAQ:MYL) rating. Cantor Fitzgerald has “Hold” rating and $41.0 target. On Tuesday, April 3 the rating was maintained by RBC Capital Markets with “Hold”.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The firm is worth $20.17 billion. The firm operates through three divisions: North America, Europe, and Rest of World.The P/E ratio is 30.14. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.